Medical Policy Updates
- RevisedTopotecan Hydrochloride (Hycamtin) Injection
- RevisedPlacement of Iliac Vein Stent
- RevisedGonadotropin-Releasing Hormone (GnRH) Receptor Antagonist [Degarelix (Firmagon™)]
- RevisedDrug Testing in Pain Management and Substance Use Disorder Treatment Settings
- RevisedDermatologic Applications of Photodynamic Therapy
- RevisedVoretigene neparvovec-rzyl (Luxturna)
- RevisedAlkylating Agent(s) [Temozolomide intravenous (Temodar®)]
- RevisedRadiation Treatment with Azedra (Iobenguane I-131)
- RevisedOxaliplatin (Eloxatin)
- RevisedGenetic Testing for Cardiac Ion Channelopathies
- RevisedGenetic Testing for the Diagnosis of Inherited Peripheral Neuropathies
- RevisedGenetic Testing for Hereditary Pancreatitis
- RevisedModerate Penetrance Variants Associated with Breast Cancer in Individuals at High Breast Cancer Risk
- RevisedBCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
- RevisedDNA-Based Testing for Adolescent Idiopathic Scoliosis
- RevisedElectromyography and Nerve Conduction Studies
- NewHemophilia Products - Congenital Factor VIII (Hemophilia A) with or without inhibitors: Hemlibra
- NewHemophilia Products – Congenital Factor XIII A-Subunit Deficiency: Tretten
- NewHemophilia Products - Congenital Factor XIII Deficiency: Corifact
- NewHemophilia Products – Factor IX (Hemophilia B): Alphanine SD, Alprolix, Bebulin, Benefix, Idelvion, Ixinity, Mononine, Profilnine, Rebinyn, and Rixubis
- NewHemophilia Products - Factor VIII (Hemophilia A) and Factor IX (Hemophilia B) with inhibitors, Acquired Hemophilia, Congenital Factor VII Deficiency, and Glanzmann’s Thrombasthenia: Novoseven RT
- NewHemophilia Products - Factor VIII (Hemophilia A) and Factor IX (Hemophilia B) with Inhibitors: Feiba NF
- NewHemophilia Products - Factor VIII (Hemophilia A) and Von Willebrand disease (VWD): Alphanate and Humate-P
- NewHemophilia Products – Factor VIII (Hemophilia A, Congenital and Acquired): Advate, Adynovate, Afstyla, Eloctate, Helixate FS, Hemofil M, Koate-DVI, Kogenate FS, Kovaltry, Monoclate-P, Novoeight, NUWIQ, Recombinate, Xyntha, Obizur, Jivi and Esperoct
- NewHemophilia Products - Factor X: Coagadex
- NewHemophilia Products – von Willebrand Factor (von Willebrand Disease): Wilate and Vonvendi
- NewOnasemnogene Abeparvovec (Zolgensma)
- NewRomosozumab-aqqg (Evenity)
